Lexeo Therapeutics, Inc.
LXEO • NASDAQ • Stock Fundamentals
Lexeo Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO R. Nolan Townsend, with a market cap of $329.8M.
Market Cap$329.8M
Employees61.0
CEOR. Nolan Townsend
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 1 month 3 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Lexeo Therapeutics, Inc. FAQ
Common questions about Lexeo Therapeutics, Inc.
Lexeo Therapeutics, Inc. (LXEO) has a market capitalization of $329.8M and trades on NASDAQ.
Lexeo Therapeutics, Inc. has approximately 61 employees.